BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23019306)

  • 21. T-cell therapy targets glioblastoma.
    Cancer Discov; 2015 May; 5(5):458. PubMed ID: 25783861
    [No Abstract]   [Full Text] [Related]  

  • 22. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
    Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
    Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.
    Choi BD; Curry WT; Carter BS; Maus MV
    Neurosurg Focus; 2018 Jun; 44(6):E13. PubMed ID: 29852773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
    Goff SL; Morgan RA; Yang JC; Sherry RM; Robbins PF; Restifo NP; Feldman SA; Lu YC; Lu L; Zheng Z; Xi L; Epstein M; McIntyre LS; Malekzadeh P; Raffeld M; Fine HA; Rosenberg SA
    J Immunother; 2019 May; 42(4):126-135. PubMed ID: 30882547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
    Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
    Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma.
    Samaha H; El Naggar S; Ahmed N
    Immunotherapy; 2015; 7(5):481-5. PubMed ID: 26065474
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growth and metastasis in lung cancer.
    Raza G; Yunus FU; Mangukiya HB; Merugu SB; Mashausi DS; Zeling W; Negi H; Zhou B; Roy D; Wu Z; Li D
    Int Immunopharmacol; 2021 Jan; 90():107155. PubMed ID: 33243603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells.
    Yan X; Su Z; Zhang J; Wu Z; Ye S; Lu X; Wu J; Zeng Y; Zheng W
    Cell Immunol; 2010; 263(2):172-5. PubMed ID: 20400066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immuno-informatics analysis and expression of a novel multi-domain antigen as a vaccine candidate against glioblastoma.
    Gharbavi M; Danafar H; Amani J; Sharafi A
    Int Immunopharmacol; 2021 Feb; 91():107265. PubMed ID: 33360829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives.
    Karschnia P; Teske N; Thon N; Subklewe M; Tonn JC; Dietrich J; von Baumgarten L
    Neurology; 2021 Aug; 97(5):218-230. PubMed ID: 33986138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
    Choi BD; Maus MV; June CH; Sampson JH
    Clin Cancer Res; 2019 Apr; 25(7):2042-2048. PubMed ID: 30446589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy.
    Firor AE; Jares A; Ma Y
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1087-98. PubMed ID: 25956686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
    Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S
    Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
    Carpenter RO; Evbuomwan MO; Pittaluga S; Rose JJ; Raffeld M; Yang S; Gress RE; Hakim FT; Kochenderfer JN
    Clin Cancer Res; 2013 Apr; 19(8):2048-60. PubMed ID: 23344265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma.
    Zheng Y; Gao N; Fu YL; Zhang BY; Li XL; Gupta P; Wong AJ; Li TF; Han SY
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):59-66. PubMed ID: 30409424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer.
    Jaén M; Martín-Regalado Á; Bartolomé RA; Robles J; Casal JI
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188802. PubMed ID: 36152905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driving CARs on the uneven road of antigen heterogeneity in solid tumors.
    Chen N; Li X; Chintala NK; Tano ZE; Adusumilli PS
    Curr Opin Immunol; 2018 Apr; 51():103-110. PubMed ID: 29554494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.
    Nguyen V; Conyers JM; Zhu D; Gibo DM; Hantgan RR; Larson SM; Debinski W; Mintz A
    Neuro Oncol; 2012 Oct; 14(10):1239-53. PubMed ID: 22952195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric antigen receptor T cell treatment in hematologic malignancies.
    Goker H; Malkan UY; Demiroglu H; Buyukasik Y
    Transfus Apher Sci; 2016 Feb; 54(1):35-40. PubMed ID: 26874466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of T Cell Redirecting Strategies: Obtaining Inspirations From Natural Process of T Cell Activation.
    Gao Y; Wang Y; Luo F; Chu Y
    Front Immunol; 2021; 12():664329. PubMed ID: 33981310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.